Steve Enger

616 total citations
30 papers, 415 citations indexed

About

Steve Enger is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Steve Enger has authored 30 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Steve Enger's work include Atrial Fibrillation Management and Outcomes (20 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Cardiac Arrhythmias and Treatments (10 papers). Steve Enger is often cited by papers focused on Atrial Fibrillation Management and Outcomes (20 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Cardiac Arrhythmias and Treatments (10 papers). Steve Enger collaborates with scholars based in Norway, Sweden and Italy. Steve Enger's co-authors include Arnljot Tveit, Michael Abdelnoor, Harald Arnesen, Knut Gjesdal, Are Hugo Pripp, Pyotr G. Platonov, Trygve Berge, Pål Smith, Odd Erik Johansen and Jonas Carlson and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Steve Enger

26 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Enger Norway 12 387 55 42 30 20 30 415
Yalçın Gökoğlan Türkiye 10 376 1.0× 25 0.5× 35 0.8× 18 0.6× 45 2.3× 50 419
D. Exner Canada 2 734 1.9× 38 0.7× 18 0.4× 15 0.5× 40 2.0× 4 750
Georgios Parcharidis Greece 12 336 0.9× 66 1.2× 30 0.7× 50 1.7× 51 2.5× 33 365
Andrei D. Mǎrgulescu Romania 11 256 0.7× 46 0.8× 21 0.5× 20 0.7× 31 1.6× 32 326
Anne H. Hobbelt Netherlands 6 587 1.5× 37 0.7× 22 0.5× 62 2.1× 43 2.1× 9 598
Sammy Khatib United States 8 232 0.6× 24 0.4× 18 0.4× 16 0.5× 19 0.9× 24 289
Étienne Aliot France 12 355 0.9× 80 1.5× 21 0.5× 26 0.9× 69 3.5× 20 383
Min Su Hyon South Korea 9 140 0.4× 35 0.6× 49 1.2× 60 2.0× 74 3.7× 30 227
Bolrathanak Oeun Japan 7 194 0.5× 25 0.5× 20 0.5× 15 0.5× 31 1.6× 17 231
Bosiljka Vujisić-Tešić Serbia 13 357 0.9× 116 2.1× 35 0.8× 48 1.6× 83 4.2× 42 387

Countries citing papers authored by Steve Enger

Since Specialization
Citations

This map shows the geographic impact of Steve Enger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Enger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Enger more than expected).

Fields of papers citing papers by Steve Enger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Enger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Enger. The network helps show where Steve Enger may publish in the future.

Co-authorship network of co-authors of Steve Enger

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Enger. A scholar is included among the top collaborators of Steve Enger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Enger. Steve Enger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Enger, Steve, Trygve Berge, Magnus Nakrem Lyngbakken, et al.. (2024). Left atrial function in middle‐aged men and women with and without paroxysmal atrial fibrillation: Data from the Akershus Cardiac Examination (ACE) 1950 study. Echocardiography. 41(6). e15852–e15852.
4.
Tveit, Arnljot, et al.. (2024). Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation. European Heart Journal - Cardiovascular Pharmacotherapy. 10(6). 515–525. 1 indexed citations
5.
6.
Janssens, Kristel, Jan Pål Loennechen, Guido Claessen, et al.. (2023). Effects of training adaption in endurance athletes with atrial fibrillation: protocol for a multicentre randomised controlled trial. BMJ Open Sport & Exercise Medicine. 9(2). e001541–e001541. 7 indexed citations
7.
Ihle‐Hansen, Håkon, Magnus Nakrem Lyngbakken, Trygve Berge, et al.. (2019). Carotid Atherosclerosis is Associated with Middle Cerebral Artery Pulsatility Index. Journal of Neuroimaging. 30(2). 233–239. 12 indexed citations
8.
Ihle‐Hansen, Håkon, Magnus Nakrem Lyngbakken, Trygve Berge, et al.. (2019). Blood pressure at age 40 predicts carotid atherosclerosis two decades later. Journal of Hypertension. 37(10). 1982–1990. 7 indexed citations
9.
Enger, Steve, et al.. (2016). Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing. BMC Cardiovascular Disorders. 16(1). 79–79. 3 indexed citations
10.
Sandberg, Frida, Valentina Corino, Luca Mainardi, et al.. (2015). Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation. Journal of Electrocardiology. 48(5). 861–866. 6 indexed citations
11.
Enger, Steve, et al.. (2015). Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population. Scandinavian Journal of Clinical and Laboratory Investigation. 75(4). 308–313. 6 indexed citations
12.
Corino, Valentina, Frida Sandberg, Pyotr G. Platonov, et al.. (2014). Non-invasive evaluation of the effect of metoprolol on the atrioventricular node during permanent atrial fibrillation. EP Europace. 16(suppl 4). iv129–iv134. 4 indexed citations
13.
Enger, Steve, Jon Norseth, Are Hugo Pripp, et al.. (2014). Improved Rate Control Reduces Cardiac Troponin T Levels in Permanent Atrial Fibrillation. Clinical Cardiology. 37(7). 422–427. 18 indexed citations
14.
Berge, Trygve, et al.. (2013). Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly. Scandinavian Journal of Clinical and Laboratory Investigation. 73(4). 326–333. 9 indexed citations
15.
Enger, Steve, Jonas Carlson, Pyotr G. Platonov, et al.. (2012). Comparison of Four Single-Drug Regimens on Ventricular Rate and Arrhythmia-Related Symptoms in Patients With Permanent Atrial Fibrillation. The American Journal of Cardiology. 111(2). 225–230. 64 indexed citations
16.
Holmqvist, Fredrik, Morten S. Olesen, Arnljot Tveit, et al.. (2010). Abnormal atrial activation in young patients with lone atrial fibrillation. EP Europace. 13(2). 188–192. 21 indexed citations
17.
Enger, Steve, et al.. (2009). Impact of atrial fibrillation on NT-proBNP levels in a 75-year-old population. Scandinavian Journal of Clinical and Laboratory Investigation. 69(5). 579–584. 7 indexed citations
18.
Johansen, Odd Erik, et al.. (2008). Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects. Cardiovascular Diabetology. 7(1). 28–28. 36 indexed citations
19.
Tveit, Arnljot, Michael Abdelnoor, Steve Enger, & Pål Smith. (2007). Atrial Fibrillation and Antithrombotic Therapy in a 75-Year-Old Population. Cardiology. 109(4). 258–262. 34 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yalçın Gökoğlan Breakdown of academic impact, for papers by D. Exner Breakdown of academic impact, for papers by Georgios Parcharidis Breakdown of academic impact, for papers by Andrei D. Mǎrgulescu Breakdown of academic impact, for papers by Anne H. Hobbelt Breakdown of academic impact, for papers by Sammy Khatib Breakdown of academic impact, for papers by Étienne Aliot Breakdown of academic impact, for papers by Min Su Hyon Breakdown of academic impact, for papers by Bolrathanak Oeun Breakdown of academic impact, for papers by Bosiljka Vujisić-Tešić
Rankless by CCL
2026